Harvard Bioscience (HBIO) Tops Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. CVI

Go back to Harvard Bioscience (HBIO) Tops Q3 EPS by 2c

Harvard Bioscience Reports Second Quarter 2018 Financial Results

July 26, 2018 4:01 PM EDT

HOLLISTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the Company), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and six months ended June 30, 2018.

I am very proud of our execution this quarter, as we not only reported record revenue, but also reported strong growth in adjusted gross profit, adjusted operating income, and adjusted earnings per share, said Jeffrey Duchemin, President and CEO of Harvard Bioscience. With a strong first half of the year, we are well on... More